Sp559
NUTRITION, OBESITY, AND EATING DISORDERS
Date
May 19, 2024
Presenter
University of Pennsylvania
Tracks
Related Products
A Multi-Disciplinary Approach to Weight Inclusive Care: From Teaching to Clinical Care
SOCIETY: AGA Optimal nutrition is essential to health and wellness and linked to outcomes of GI and liver diseases. However, gastroenterologists are not equipped with the nutrition knowledge/resources necessary to provide holistic care for patients with digestive diseases…
OUTCOMES ASSOCIATED WITH GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST USE IN PATIENTS UNDERGOING OUTPATIENT UPPER ENDOSCOPY
BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP1RAs) are associated with delayed gastric emptying, which has raised concerns regarding the risk of adverse anesthesia events (e.g., aspiration) among GLP1RA-treated patients…
SAFETY AND CLINICAL EFFECTIVENESS OF GLP1 AGONISTS IN INFLAMMATORY BOWEL DISEASE PATIENTS
Obesity is prevalent within the inflammatory bowel disease (IBD) population. Several studies suggest that 15%-40% of IBD patients are obese. Obesity has further been associated with higher disease activity and reduced time to flare…
NUTRITION, OBESITY AND EATING DISORDERS
The AGA Board Review Course held annually at DDW provides attendees with the information they need to stay current in their practice and prepare for both the ABIM recertification and initial certification exams in gastroenterology…
